Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
March 16, 2010
PALO ALTO, Calif., March 16, 2010 /PRNewswire via COMTEX/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that Robert Myers, the company's President, will present at the Barclays Capital 2010 Global Healthcare Conference on Wednesday, March 24, 2010 at 8:00 a.m. Eastern Time at The Loews Miami Hotel in Miami, Florida.
After the presentation, the slides may be accessed by visiting the Investors section of the Jazz Pharmaceuticals website at http://www.JazzPharmaceuticals.com. The slides will be available for two weeks following the presentation.
About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.JazzPharmaceuticals.com.
SOURCE Jazz Pharmaceuticals, Inc.